Merck's Keytruda rides breast cancer hot streak to frontline chemo-combo win

12th February 2020 Uncategorised 0

Merck’s Keytruda may have stumbled early in its candidacy as a triple-negative breast cancer treatment, but those days seem to be behind it. The immuno-oncology star, in tandem with chemo, has now topped solo chemo at staving off disease progression in patients with certain levels of biomarker PD-L1.

More: Merck's Keytruda rides breast cancer hot streak to frontline chemo-combo win
Source: fierce